RNA-seq, as previously mentioned, is a powerful tool for the detection of gene fusions; it has been used to detect the presence of the NUTM1 (NUT midline carcinoma family member 1) rearrangement in B-ALL patients, which appears to be associated with a favorable prognosis [56]. The gene discussed is NUTM1; the disease is acute lymphoblastic leukemia.